An mRNA Cancer Vaccine Just Passed Its Biggest Test. AI Helped.

One company has developed a technology that extracts valuable resources from coal without burning it. From jet fuel to diesel and more, Frontieras North America has the potential to address $2.1  trillion in annual markets*.

It’s similar to when John D. Rockefeller commercialized oil refining technology. If Frontieras captures just 2% of the global coal market, they would position themselves as the global leader in the space.

They just broke ground for their $850 million flagship facility and reserved the ‘FASF’ NASDAQ ticker. Don’t miss your chance to join the next phase of growth: invest in Frontieras before the opportunity ends on August 27.

Learn More

^{Frontieras is offering securities through the use of an Offering Statement that has been qualified by the Securities and Exchange Commission under Tier II of Regulation A. A copy of the Final Offering Circular that forms a part of the Offering Statement may be obtained from: invest.frontieras.com.  Reservation of the ticker symbol is not a guarantee that we will be listed on the NASDAQ. Listing on the NASDAQ is subject to approvals.   Sources* The global market for our products is worth a combined value of over $2.1 trillion.}

1.  OpenAI launches a separate ChatGPT for teens. 

Users aged 13 to 17 now get a locked-down version of ChatGPT with stronger content guardrails, a learning-first study mode, and parental controls like quiet hours. An age prediction system routes suspected minors into the teen experience automatically, so lying about a birthdate no longer works. Parents also get notified on high-risk safety events. Read the full breakdown at Axios.

2.  Google hands college students a free year of AI Pro. 

US college students can claim 12 months of Google AI Pro, normally $19.99 a month, by verifying enrollment before December 31, 2026. The plan includes four times higher Gemini usage limits, Gemini inside Gmail and Docs, and 5 TB of storage. Students outside the US get a free year of the cheaper AI Plus tier instead. See the offer details on Google's blog.

3.  Amazon makes Alexa+ free on every Fire TV. 

Amazon is upgrading all compatible Fire TV devices in the US to its AI assistant Alexa+ at no cost, dropping the $19.99 monthly fee non-Prime users paid before. You can now ask for a top-rated thriller and then narrow it down conversationally, the way you would with a friend. Amazon says Alexa+ owners talk to their TVs nearly twice as much as they did with the old Alexa. TechCrunch has the details.

The setup. Moderna and Merck announced this week that intismeran, a personalized mRNA cancer vaccine, succeeded in a Phase 3 melanoma trial of more than 1,100 patients. Paired with Merck's immunotherapy Keytruda after surgery, it cut the risk of the cancer returning and of spreading to other parts of the body. It is the first positive Phase 3 readout for any cancer vaccine, ever. STAT has the announcement.

How it works. Doctors sequence each patient's tumor, then prediction algorithms pick which mutant proteins, called neoantigens, will best train that person's immune system. Moderna encodes those targets as mRNA and manufactures a vaccine built for exactly one human being. One trial investigator told Nature that medicine had never been able to train an individual patient's immune system against their own tumor before. Read the science at Nature.

The market verdict. Moderna shares soared about 177% on the news, while Merck climbed more than 12% on top of a $333 billion market cap. CEO Stephane Bancel called it as big a day for humanity as November 16, 2020, when Moderna's COVID vaccine results landed. CNBC has the numbers.

What comes next. The companies will now file with regulators, and trials of the same approach are running in lung, bladder, kidney, pancreatic, and stomach cancers, with results expected over the next year or two. Roche and BioNTech are testing a rival personalized vaccine in colon and pancreatic cancer patients. CNN maps the coming wave.

The reframe. The COVID shots proved mRNA could scale to billions of identical doses. This result proves the opposite trick: a drug designed by computation and manufactured in a batch of one. If that holds across other cancers, the most valuable ingredient in medicine stops being the molecule and becomes the data pipeline that designs it.

Drone summer. Amazon plans to expand Prime Air drone delivery to nearly 500 US cities and towns by the end of 2026, a sixfold jump from today, with sub-five-pound packages arriving in as fast as 30 minutes. See the expansion map.

Study buddy hub. Google shipped a dedicated student hub inside Gemini with flashcards, practice quizzes, and interactive 3D models you can rotate, like a spinning DNA strand. Tom's Guide walks through it.

Hands-free research. Deep Research now works inside Gemini Live, so you can start a full research report by voice, lock your phone, and get a notification when it is ready. The Next Web explains the update.

Claude goes auto. Anthropic made auto mode the default in Claude Code after a study of 1,053 testers found humans caught only 13.6% of dangerous commands, while its safety classifier caught 89%. 9to5Mac has the numbers.

A paradigm shift. Moderna cofounder Robert Langer, the MIT professor who built the nanoparticles that carry mRNA into the body, says he sees no reason the personalized vaccine approach would not work on other cancers too. The Boston Globe has his take.

Turn any syllabus into a personal study plan

Back-to-school timing, meet AI. This prompt works in ChatGPT, Claude, or Gemini and converts a messy syllabus into a week-by-week study plan with built-in quizzes and spaced repetition. Paste it in before the semester buries you.

Swap [SUBJECT OR COURSE NAME] with anything from Financial Accounting to IELTS Writing to Python Basics. For a harder push, add one extra line: quiz me at the start of every session on the previous day's material.